|
Delayed
NYSE
04:56:46 24/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.1707 USD | -3.56% |
|
+3.39% | -70.87% |
| 20/08 | Top Premarket Decliners | MT |
| 14/08 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.56% | +3.39% | -13.13% | -73.74% | -70.87% | -91.20% | -97.27% | -99.76% | -99.79% | 2.6M | |
| +0.06% | +7.20% | +3.13% | +57.21% | +85.29% | +54.04% | +111.13% | +9.49% | - | 74.27B | |
| -2.29% | -1.51% | -3.29% | +2.80% | +16.60% | +33.30% | +75.15% | +209.56% | +5,416.83% | 61.21B | |
| +0.28% | +7.27% | +3.53% | +71.76% | +67.94% | +31.74% | +23.80% | -56.54% | - | 27.55B | |
| -1.71% | -3.36% | -4.45% | +15.97% | -31.94% | -18.52% | +359.50% | +329.51% | +702.57% | 26.38B | |
| -1.89% | +3.43% | -12.15% | +9.37% | +4.11% | +0.86% | -3.88% | -71.92% | - | 25.34B | |
| +0.57% | +3.66% | +8.52% | +34.15% | +13.07% | +25.59% | -9.08% | -18.92% | +100.52% | 20.84B | |
| -1.47% | +4.46% | -10.22% | +23.09% | +23.15% | -8.09% | +513.33% | - | - | 14.94B | |
| +1.29% | -2.49% | -16.07% | +19.03% | +177.32% | +163.31% | +333.06% | +1,388.09% | +653.35% | 15.17B | |
| -2.32% | +0.04% | +4.13% | +10.64% | +29.60% | +42.69% | +160.22% | +177.10% | +281.50% | 14.41B | |
| -3.97% | -5.29% | +28.71% | +14.98% | -6.32% | -14.44% | +753.39% | +204.55% | +87.69% | 13.66B | |
| -0.42% | -3.37% | -0.14% | -0.42% | -12.20% | +15.32% | +238.72% | +501.78% | +4,288.58% | 11.99B | |
| +1.67% | +2.36% | +8.03% | +17.54% | -13.72% | -25.57% | +160.00% | +133.25% | - | 11.26B | |
| -7.01% | +1.65% | -22.89% | -16.30% | +0.73% | +105.77% | +150.75% | +3.36% | +826.25% | 10.15B | |
| -3.01% | -6.11% | -15.49% | -18.57% | +2.53% | +34.19% | +117.31% | +93.84% | +643.72% | 9.4B | |
| -6.94% | +9.86% | +14.64% | +18.72% | +338.89% | +235.52% | +439.75% | -18.86% | - | 9.85B | |
| -5.14% | -5.00% | -9.76% | +7.45% | +21.00% | +68.42% | +9.82% | +113.25% | - | 8.78B | |
| -0.69% | +4.44% | -0.13% | +18.05% | +9.44% | -24.23% | +94.81% | -23.20% | - | 8.71B | |
| -3.94% | -3.59% | -17.58% | -9.43% | +168.32% | +448.69% | +655.80% | -54.75% | -45.82% | 8.11B | |
| -2.88% | -0.87% | +5.58% | +15.61% | +4.86% | +136.09% | +436.42% | - | - | 7.06B | |
| Average | -2.10% | +3.02% | -2.45% | +10.90% | +41.39% | +60.67% | +226.14% | +156.66% | +1,168.67% | 18.95B | |
| Weighted average by Cap. | -1.46% | +2.76% | -1.05% | +23.88% | +44.49% | +48.45% | +181.93% | +149.70% | +2,262.41% |
- Stock Market
- Stocks
- MTNB Stock
- Sector Matinas BioPharma
Select your edition
All financial news and data tailored to specific country editions
